These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20571518)

  • 1. In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.
    Milak MS; Severance AJ; Prabhakaran J; Kumar JS; Majo VJ; Ogden RT; Mann JJ; Parsey RV
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):243-9. PubMed ID: 20571518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.
    Milak MS; DeLorenzo C; Zanderigo F; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2010 Dec; 51(12):1892-900. PubMed ID: 21098796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No change in [¹¹C]CUMI-101 binding to 5-HT(1A) receptors after intravenous citalopram in human.
    Pinborg LH; Feng L; Haahr ME; Gillings N; Dyssegaard A; Madsen J; Svarer C; Yndgaard S; Kjaer TW; Parsey RV; Hansen HD; Ettrup A; Paulson OB; Knudsen GM
    Synapse; 2012 Oct; 66(10):880-4. PubMed ID: 22730164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.
    Milak MS; Severance AJ; Ogden RT; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2008 Apr; 49(4):587-96. PubMed ID: 18344443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study.
    Selvaraj S; Turkheimer F; Rosso L; Faulkner P; Mouchlianitis E; Roiser JP; McGuire P; Cowen PJ; Howes O
    Mol Psychiatry; 2012 Dec; 17(12):1254-60. PubMed ID: 22665264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.
    Udo de Haes JI; Cremers TI; Bosker FJ; Postema F; Tiemersma-Wegman TD; den Boer JA
    Neuropsychopharmacology; 2005 Sep; 30(9):1624-31. PubMed ID: 15827572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: a continuous infusion PET study in conscious monkeys.
    Udo de Haes JI; Harada N; Elsinga PH; Maguire RP; Tsukada H
    Synapse; 2006 Jan; 59(1):18-26. PubMed ID: 16237679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain.
    Shrestha SS; Liow JS; Lu S; Jenko K; Gladding RL; Svenningsson P; Morse CL; Zoghbi SS; Pike VW; Innis RB
    J Nucl Med; 2014 Jan; 55(1):141-6. PubMed ID: 24385311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
    Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P
    Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.
    Hines CS; Liow JS; Zanotti-Fregonara P; Hirvonen J; Morse C; Pike VW; Innis RB
    PLoS One; 2011; 6(9):e25309. PubMed ID: 21980419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubis.
    Ridler K; Plisson C; Rabiner EA; Gunn RN; Easwaramoorthy B; Abi-Dargham A; Laruelle M; Slifstein M
    Synapse; 2011 Nov; 65(11):1119-27. PubMed ID: 21538549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of high and low affinity serotonin 1A receptors by PET in vivo in nonhuman primates.
    Kumar JS; Milak MS; Majo VJ; Prabhakaran J; Mali P; Savenkova L; Mann JJ; Parsey RV
    J Pharmacol Sci; 2012; 120(3):254-7. PubMed ID: 23076129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine.
    Hume S; Hirani E; Opacka-Juffry J; Myers R; Townsend C; Pike V; Grasby P
    Synapse; 2001 Aug; 41(2):150-9. PubMed ID: 11400181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala.
    Bosker FJ; Cremers TI; Jongsma ME; Westerink BH; Wikström HV; den Boer JA
    J Neurochem; 2001 Mar; 76(6):1645-53. PubMed ID: 11259482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.
    Kumar JS; Parsey RV; Kassir SA; Majo VJ; Milak MS; Prabhakaran J; Simpson NR; Underwood MD; Mann JJ; Arango V
    Brain Res; 2013 Apr; 1507():11-8. PubMed ID: 23454434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study.
    Frey BN; Rosa-Neto P; Lubarsky S; Diksic M
    Neuroimage; 2008 Aug; 42(2):850-7. PubMed ID: 18583156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo evaluation of the serotonin 1A receptor partial agonist [³H]CUMI-101 in awake rats.
    Palner M; Underwood MD; Kumar DJ; Arango V; Knudsen GM; John Mann J; Parsey RV
    Synapse; 2011 Aug; 65(8):715-23. PubMed ID: 21108237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.
    Stenkrona P; Halldin C; Lundberg J
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1190-8. PubMed ID: 23428337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.